Drug Trial Radar · NCT07198139
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Feb 23, 2026
Primary completion
Sep 14, 2026
Study completion Sep 14, 2026
Sponsor
- Lead sponsor
- Cocrystal Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Participants in this study will be given either CDI-988 or placebo orally before receiving a norovirus challenge virus and continuing for 5 days. Participants will not know whether they are getting placebo or CDI-988. The study will evaluate how well CDI-988 compared to placebo can reduce the incidence of clinical symptoms after a challenge with norovirus. The amount of virus in stool samples will be measured over time. Side effects and pharmacokinetics (the amount of CDI-988 in blood) will also be measured.
Conditions
- Norovirus
Interventions
CDI-988Drug
Antiviral to treat norovirus
PlaceboDrug
Matching placebo
Snow Mountain VirusOther
Challenge with Snow Mountain Virus
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of norovirus-confirmed diseaseTime frame: Day 0 to Day 21
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hope Clinic of the Emory Vaccine Center
Decatur, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.